29 completed, 5 terminated, 5 unknown, 3 withdrawn. 18 Phase 3, 12 Phase 4, 5 Not applicable, 5 Phase 2, 3 Phase 1.
Follow alfuzosin: new trials by email Literature Review of alfuzosin trials Research Report on alfuzosin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed Conditions Alfuzosin Hydrochloride 10 mg, Xatral® XL 10 mg - Healthy Vollunteer | Phase 1 | Unknown | Pharma Nueva | 44 | 2024-06-10 | 2024-03-18 |
| The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets, Xatral® XL 10 mg - Healthy Volunteer | Phase 1 | Unknown | International Bio service | 44 | 2024-03-09 | 2024-01-29 |
| The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil Alfuzosin Hydrochloride 10 MG, Tamsulosin Hydrochloride 0.4 MG - Benign Prostatic Hyperplasia, Pupil Anomaly | Phase 4 | Completed | Kocatepe University | 63 | 2015-10-29 | 2017-05-09 |
| Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia Odyliresin, Alfuzosin - Benign Prostatic Hypertrophy With Outflow Obstruction, Benign Prostatic Hyperplasia | Not applicable | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 30 | 2015-01-01 | 2017-02-28 |
| Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions Alfuzosin, Placebo - Constipation | Phase 2 | Completed | Mayo Clinic | 74 | 2013-03-01 | 2019-01-29 |
| An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms Placebo, Alfuzosin - Erectile Dysfunction, Lower Urinary Tract Symptoms | Phase 3 | Completed | Chesapeake Urology Research Associates | 74 | 2009-06-01 | 2018-03-09 |
| Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female alfuzosin hydrochloride XL 10mg, Placebo - Voiding Dysfunction | Phase 2 | Completed | Samsung Medical Center | 190 | 2008-06-01 | 2013-06-10 |
| The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia selective alpha 1-blockers, celecoxib, alpha-blocker and NSAID - Benign Prostatic Hyperplasia | Phase 4 | Withdrawn | Samsung Medical Center | 2008-05-01 | 2013-06-10 | |
| Alfuzosin for Medical Expulsion Therapy of Ureteral Stones Alfuzosin, nifedipine, doxazosin - Kidney Stones | Phase 3 | Unknown | United States Naval Medical Center, San Diego | 240 | 2008-01-01 | 2012-04-27 |
| Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology Alfuzosin - Hydronephrosis, Neurogenic Bladder | Phase 3 | Completed | Sanofi | 25 | 2007-12-01 | 2014-10-29 |
| Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) Alfuzosin - Multiple Sclerosis, Bladder Dysfunction | Phase 2 / Phase 3 | Terminated | Nova Scotia Health Authority | 20 | 2007-11-01 | 2011-06-27 |
| A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones Alfuzosin (Xatral), Placebo Alfuzosin - Kidney Stones | Not applicable | Withdrawn | Unity Health Toronto | 2007-10-01 | 2015-07-31 | |
| Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction Alfuzosin, Placebo - Neurogenic Urinary Bladder | Phase 3 | Completed | Sanofi | 172 | 2007-10-01 | 2014-10-29 |
| The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones Alfuzosin, Tamsulosin - Renal Colic | Phase 4 | Unknown | Soroka University Medical Center | 120 | 2007-04-01 | 2012-07-12 |
| Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia alfuzosin - Prostatic Hyperplasia | Phase 3 | Completed | Sanofi | 1177 | 2006-11-01 | 2009-10-02 |
| Use of Alfuzosin in Stone Treatment With ESWL Alfuzosin (Xatral), standard treatment - Urinary Calculi | Phase 3 | Withdrawn | Singapore General Hospital | 2006-10-01 | 2017-02-10 | |
| Benign Prostatic Hyperplasia in Taiwan Alfuzosin (XATRAL® - SL770499) - Prostatic Diseases | Not applicable | Completed | Sanofi | 362 | 2006-09-01 | 2010-03-30 |
| Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study ALFUZOSIN - Prostatic Hyperplasia | Phase 4 | Completed | Handok Inc. | 125 | 2006-09-01 | 2007-11-29 |
| ALF-STONE: Alfuzosin in Uretheric Stones Alfuzosin - Prostatic Hyperplasia | Phase 3 | Terminated | Sanofi | 220 | 2006-08-01 | 2007-09-24 |
| Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology alfuzosin (SL770499) - Urinary Bladder Neurogenic | Phase 3 | Completed | Sanofi | 29 | 2006-07-01 | 2009-12-15 |
Showing 20 of 42. Sign in to see all of them.
Prostatic Hyperplasia (17) · Kidney Calculi (3) · Urinary Bladder, Neurogenic (3) · Urinary Retention (3) · Erectile Dysfunction (2) · Lower Urinary Tract Symptoms (2) · Prostatic Diseases (2) · Acute Disease (1) · Choroid Diseases (1) · Colic (1) · Constipation (1) · Hydronephrosis (1) · Multiple Sclerosis (1) · Neoplasms (1) · Prostatic Neoplasms (1)
Sanofi (18) · Samsung Medical Center (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · University of Minnesota (2) · Asan Medical Center (1) · Boehringer Ingelheim (1) · Chesapeake Urology Research Associates (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Handok Inc. (1) · Hospital Authority, Hong Kong (1) · International Bio service (1) · Kocatepe University (1) · Mayo Clinic (1) · New York Prostate Institute (1) · Nova Scotia Health Authority (1)
United States (13) · Canada (6) · South Korea (5) · Bulgaria (3) · Poland (3) · Portugal (3) · Serbia (3) · Singapore (3) · Taiwan (3) · China (2) · Denmark (2) · Estonia (2) · Hungary (2) · India (2) · Israel (2)
Kyu-Sung Lee, Ph.D (2) · Manoj Monga, MD (2) · Porranee Puranajoti (2) · Adil Bharucha, MBBS, MD (1) · Allen D Seftel, MD (1) · Benedict Blayney, MD (1) · Brian K. Auge, M.D. (1) · Bruno Jolain (1) · Carlos Santos, MD (1) · Carmine Tinelli, MD (1) · Chi Wai Cheng, Dr (1) · Eran Rosenberg, M.D (1) · Henning Andersen, MD (1) · Hyou-Young Rhim, Dr. (1)
PMID 16536764, PMID 19092152, PMID 21251673, PMID 30130627
2004 (2), 1UL1RR024150 (1), R01DK078924 (1), U01DK060817 (1), U01DK065209 (1)